Redox Modulation of Mitochondrial Proteins in the Neurotoxicant Models of Parkinson's Disease

被引:6
作者
Sarkar, Alika [1 ,2 ]
Rasheed, Mohd Sami Ur [1 ,2 ]
Singh, Mahendra Pratap [1 ,2 ]
机构
[1] CSIR Indian Inst Toxicol Res CSIR IITR, Toxicogen & Predict Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India
[2] Acad Sci & Innovat Res AcSIR, Ghaziabad, India
关键词
PD; redox modulation; mitochondrial protein; neurotoxicant; oxidative stress; COMPLEX-I INHIBITION; TARGETED ANTIOXIDANT MITOQ; CYSTEINE-SULFINIC ACID; MPTP MOUSE MODEL; OXIDATIVE STRESS; SUBSTANTIA-NIGRA; S-NITROSYLATION; DOPAMINERGIC-NEURONS; CELL-DEATH; INCREASED SUSCEPTIBILITY;
D O I
10.1089/ars.2022.0106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Mitochondrial proteins regulate the oxidative phosphorylation, cellular metabolism, and free radical generation. Redox modulation alters the mitochondrial proteins and instigates the damage to dopaminergic neurons. Toxicants contribute to Parkinson's disease (PD) pathogenesis in conjunction with aging and genetic factors. While oxidative modulation of a number of mitochondrial proteins is linked to xenobiotic exposure, little is known about its role in the toxicant-induced PD. Understanding the role of redox modulation of mitochondrial proteins in complex cellular events leading to neurodegeneration is highly relevant.Recent Advances: Many toxicants are shown to inhibit complex I or III and elicit free radical production that alters the redox status of mitochondrial proteins. Implication of redox modulation of the mitochondrial proteins makes them a target to comprehend the underlying mechanism of toxicant-induced PD.Critical Issues: Owing to multifactorial etiology, exploration of onset and progression and treatment outcomes needs a comprehensive approach. The article explains about a few mitochondrial proteins that undergo redox changes along with the promising strategies, which help to alleviate the toxicant-induced redox imbalance leading to neurodegeneration.Future Directions: Although mitochondrial proteins are linked to PD, their role in toxicant-induced parkinsonism is not yet completely known. Preservation of antioxidant defense machinery could alleviate the redox modulation of mitochondrial proteins. Targeted antioxidant delivery, use of metal chelators, and activation of nuclear factor erythroid 2-related factor 2, and combinational therapy that encounters multiple free radicals, could ameliorate the redox modulation of mitochondrial proteins and thereby PD progression.
引用
收藏
页码:824 / 852
页数:29
相关论文
共 50 条
  • [31] Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential
    Henrich, Martin T.
    Oertel, Wolfgang H.
    Surmeier, D. James
    Geibl, Fanni F.
    MOLECULAR NEURODEGENERATION, 2023, 18 (01)
  • [32] Mitochondrial kinases in Parkinson's disease: Converging insights from neurotoxin and genetic models
    Dagda, Ruben K.
    Zhu, Jianhui
    Chu, Charleen T.
    MITOCHONDRION, 2009, 9 (05) : 289 - 298
  • [33] Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease
    Franco-Iborra, Sandra
    Vila, Miquel
    Perier, Celine
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [34] Mitochondrial and Organellar Crosstalk in Parkinson's Disease
    Ray, Bipul
    Bhat, Abid
    Mahalakshmi, Arehally Marappa
    Tuladhar, Sunanda
    Bishir, Muhammed
    Mohan, Surapaneni Krishna
    Veeraraghavan, Vishnu Priya
    Chandra, Ramesh
    Essa, Musthafa Mohamed
    Chidambaram, Saravana Babu
    Sakharkar, Meena Kishore
    ASN NEURO, 2021, 13
  • [35] Mitochondrial calcium imbalance in Parkinson's disease
    Ludtmann, Marthe H. R.
    Abramov, Andrey Y.
    NEUROSCIENCE LETTERS, 2018, 663 : 86 - 90
  • [36] The Mitochondrial Cascade Hypothesis for Parkinson's Disease
    Cardoso, Sandra M.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (31) : 3390 - 3397
  • [37] Control of mitochondrial integrity in Parkinson's disease
    Vives-Bauza, Cristofol
    Tocilescu, Maja
    de Vries, Rosa L. A.
    Alessi, Dana M.
    Jackson-Lewis, Vernice
    Przedborski, Serge
    RECENT ADVANCES IN PARKINSONS DISEASE: BASIC RESEARCH, 2010, 183 : 99 - 113
  • [38] Unravelling mitochondrial pathways to Parkinson's disease
    Celardo, I.
    Martins, L. M.
    Gandhi, S.
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (08) : 1943 - 1957
  • [39] The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease
    Chen, Zixuan
    Rasheed, Madiha
    Deng, Yulin
    BRAIN PATHOLOGY, 2022, 32 (03)
  • [40] Post-translational modification and mitochondrial function in Parkinson's disease
    Luo, Shishi
    Wang, Danling
    Zhang, Zhuohua
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2024, 16